-
1
TNG908 is a brain-penetrant, MTA-cooperative PRMT5 inhibitor developed for the treatment of MTAP-deleted cancers
Published 2025-02-01Subjects: “…PRMT5…”
Get full text
Article -
2
PRMT5 Inhibitor EPZ015666 Decreases the Viability and Encystment of <i>Entamoeba invadens</i>
Published 2024-12-01Subjects: Get full text
Article -
3
Inhibitory Effect of PRMT5/MTA Inhibitor on MTAP‐Deficient Glioma May Be Influenced by Surrounding Normal Cells
Published 2024-12-01Subjects: Get full text
Article -
4
Prmt5 is essential for intestinal stem cell maintenance and homeostasis
Published 2025-02-01Subjects: “…Prmt5…”
Get full text
Article -
5
PRMT5 promotes ovarian cancer growth through enhancing Warburg effect by methylating ENO1
Published 2023-04-01Subjects: “…protein arginine methyltransferase 5 (PRMT5)…”
Get full text
Article -
6
PRMT5 inhibition has a potent anti-tumor activity against adenoid cystic carcinoma of salivary glands
Published 2025-01-01Subjects: “…Protein arginine methyl transferase 5 (PRMT5)…”
Get full text
Article